Verona Pharma plc Financial Flexibility Index
Verona Pharma plc financial flexibility index. Verona Pharma plc (I9SA) has a Financial Flexibility Index of 0.10x as of June 2025. Free cash flow of €30.56 Million (operating CF €30.56 Million minus capex €0.00) represents 0% of total liabilities (€294.60 Million). See Verona Pharma plc (I9SA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Verona Pharma plc (2016–2024)
Financial flexibility index of Verona Pharma plc from 2016 to 2024. Historical Financial Flexibility Index trend for Verona Pharma plc across 9 annual periods. Check I9SA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Verona Pharma plc Financial Flexibility Index by Year (2016–2024)
Verona Pharma plc financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Verona Pharma plc. For the full cash flow conversion analysis, see cash flow conversion of Verona Pharma plc.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | €-121.62 Million | €-122.20 Million | €269.68 Million | ▲ +47.2% |
| 2023 | -0.85x | €-50.22 Million | €-50.22 Million | €58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | €-59.83 Million | €-59.86 Million | €29.00 Million | ▼ -139.4% |
| 2021 | -0.86x | €-33.24 Million | €-33.25 Million | €38.58 Million | ▲ +62.9% |
| 2020 | -2.33x | €-44.99 Million | €-45.08 Million | €19.35 Million | ▲ +19.8% |
| 2019 | -2.90x | €-42.81 Million | €-42.87 Million | €14.78 Million | ▼ -130.1% |
| 2018 | -1.26x | €-18.10 Million | €-18.11 Million | €14.37 Million | ▲ +20.8% |
| 2017 | -1.59x | €-20.69 Million | €-20.70 Million | €13.00 Million | ▼ -322.1% |
| 2016 | -0.38x | €-5.43 Million | €-5.59 Million | €14.40 Million | — |